Exercise improves quality of life for patients with bone metastases
the ONA take:
According to new findings presented at the Clinical Oncology Society of Australia's (COSA's) Annual Scientific Meeting in Melbourne, Australia, resistance training and aerobic exercise programs specifically designed to avoid injuring fragile areas of bone metastases are safe and more effective than avoiding physical activity for patients with cancer and bone metastases.
Researchers at the Edith Cowan University Health and Wellness Institute in Perth, Australia, investigated the effects of an individualized exercise program for patients with breast and prostate cancer who have metastases in the bone. The exercise programs maintained training to the body while avoiding the fragile bone sites caused by metastases.
Results showed that patients in the intervention group had improved neuromuscular strength, aerobic fitness, walking speed, physical activity, and muscle mass with no increases in bone pain or adverse events.
Most patients with cancer are often advised to exercise, but patients with skeletal metastases are the exception. The findings suggest that remaining active while avoiding fragile areas can improve quality of life without increasing the number of adverse events.
The authors note that patients with cancer who have bone metastases who are treated with this exercise intervention should be monitored closely by an exercise physiologist.
Resistance training programs designed to avoid injuring fragile areas of bone metastases are safe.
- Immunotherapy May Benefit Some Patients with Papillary Thyroid Carcinoma
- New Study Questions Standard Dosage for Treating Metastatic Non-Small Cell Lung Cancer
- Clinical Trials May Benefit Oncology Patients
- Breast Cancer Overdiagnosis Also a Result of Screening Mammography Programs
- Prostate-specific PET and CT Imaging Improves Detection of Disease and Patient Care
- Survivorship Care Plans: Providing A Blueprint for Health Care After Cancer
- Cancer Recurrence Fear Reduced by Novel Psychological Intervention
- Multifaceted Role of the Nurse Navigator Includes Palliative, Supportive Care
- Patient Navigators Found to Boost Lung Cancer Screening Rates
- Breast Cancer Diagnosis and Nurse Navigation Survey
- Novel 3D Marker Reduces Radiation, Improves Cosmesis in Breast Conserving Surgery
- Rates at Some Milestones May Indicate Clinical Trial Results for Immunotherapeutics
- Cancer Risks for BRCA1/2 Mutation Carriers Determined by Age, Family History, Mutation Location
- Long-Term Use of TPO Receptor Agonist Safe in CLL-Associated Immune Thrombocytopenia
- Savolitinib Active, Tolerable in Subset of Advanced Papillary Renal Cell Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|